---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-002254"
form_type: "8-K"
ticker: "ALUR"
cik: "0001964979"
company_name: "ALLURION TECHNOLOGIES, INC."
filed_at: "2025-01-06T23:59:59+00:00"
generated_at: "2026-05-28T11:34:30.307188+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Allurion appoints R. Jason Richey to Board as Class II director

## Summary
- Board size increased from 8 to 9; Richey appointed effective December 30, 2024.
- Richey is an independent consultant to RTW Investments, a company stockholder.
- Previously president/CEO of Cytrellis Biosystems and president of Cutera (CUTR).
- Compensation consistent with Allurion's non-employee director compensation policy.
- No other arrangement or material interest in transactions with the company.

## SEC filing metadata
- accession: 0001193125-25-002254
- form_type: 8-K
- ticker: ALUR
- cik: 0001964979
- company_name: ALLURION TECHNOLOGIES, INC.
- filed_at: 2025-01-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964979/000119312525002254/0001193125-25-002254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964979/000119312525002254/d912660d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-002254
- JSON: https://secwatch.observer/filing/0001193125-25-002254.json
- Plain text: https://secwatch.observer/filing/0001193125-25-002254.txt

## Source-grounded claims
- claim_id: 411bfd1b52
  claim: R. Jason Richey was appointed as Class II Director at ALLURION TECHNOLOGIES, INC..
  evidence_excerpt: appointed R. Jason Richey to the Board as a Class II director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1964979/000119312525002254/0001193125-25-002254-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.